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Abstract: Maintenance of intestinal barrier integrity is crucial for preventing inflammatory bowel 15 
diseases (IBDs) onset and exacerbations. In this work we study the effect of a fixed combination of 16 
Lactobacillus reuteri and Lactobacillus acidophilus and herbal extracts in an in vitro inflammation 17 
experimental model. Caco-2 cell monolayer was exposed to INF-γ+TNF-α or to LPS; Trans Epithelial 18 
Electrical Resistance (TEER) and paracellular permeability were investigated. ZO-1 and occludin 19 
tight junctions (TJs) were also investigated by mean of immunofluorescence. The pre-treatment with 20 
the fixed combination of probiotics and herbal extracts prevented the inflammation-induced TEER 21 
decrease, paracellular permeability increase and TJs translocation. In summary the fixed 22 
combination of probiotics and herbal extracts investigated in this research was found to be an 23 
interesting candidate for targeting the re-establishment of intestinal barrier function in IBDs 24 
conditions. 25 
Keywords: IBD; intestinal barrier; Lactobacillus reuteri; Lactobacillus acidophilus; Trans Epithelial 26 
Electrical Resistance (TEER) 27 
 28 
1. Introduction 29 
Intestinal barrier dysfunctions are strictly linked to inflammatory bowel diseases (IBD) such as 30 
Chron’s disease and ulcerative colitis 1. In fact, an increase of intestinal epithelial cells permeability 31 
leads to a strong antigenic response, primarily affected by microbial hosts and post digestive toxins 32 
2. The management of intestinal inflammation is pivotal to avoid exacerbations and autoimmune 33 
diseases onset and, thus, non-steroidal anti-inflammatory drugs such as aminosalicylates, or 34 
glucocorticoids are commonly used 3. In case of active IBDs and severe symptoms, 35 
immunosuppressive drugs are also used [4]; nevertheless, intestinal barrier homeostasis and 36 
maintenance is scarcely considered in conventional pharmacotherapy and currently the interest in 37 
integrative and complementary therapies is increasing 5. Elevated levels of reactive oxygen and 38 
nitrogen species (ROS and RNS) and increased release of pro-inflammatory cytokines are, 39 
respectively, very relevant in initiation and progression of intestinal barrier dysregulation 1. These 40 
considerations have been suggesting that antioxidant and anti-inflammatory agents could be 41 
conveniently used and recently our group demonstrated how Boswellia serrata Roxb. gum resin and 42 
its chemical marker acetyl-11-keto--boswellic acid (AKBA) resulted to be effective in preserving 43 
Caco-2 intestinal epithelial cells barrier capacity ameliorating oxidative inflammatory and 44 
permeability parameters after H202 and INF-γ and TNF α stimuli [1]. Other natural products and 45 
dietary supplements were investigated in intestinal barrier regulation. Beside to natural compounds 46 
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aspecifically able to inhibit proinflammatory cytokines release or macrophage activation, such as 47 
berberine, catechins, baicalin, lupeol or curcumin 6 or able to decrease ROS levels, such as 48 
anthocyanosides, resveratrol, flavonoids and, again, catechins or curcumin 7 to cite the most studied 49 
ones, other phytoconstituents were found to interact with specific transcription factor, such as NF-B 50 
and pregnane X receptors (PXR). Andrographolide, a major constituent of Andrographis paniculata 51 
(Burm.f.) Wall. ex Nees was found to inhibit NF-B and CD4+ T cells infiltration to lamina propria and 52 
differentiation. Baicalein, a constituent of Scutellaria baicalensis Georgi activates PXR by promoting 53 
the binding of caudal type homeobox 2 to PXR promoter. Piperine is another natural compound able 54 
to increase PXR activity 6. 55 
Probiotics represent a new perspective in regulating intestinal barrier functions 8-9: the most recent 56 
systematic review 10 underlined that, despite need of further clinical investigations, the use of 57 
probiotics in association with conventional therapies is likely linked to an improvement of the overall 58 
induction and maintenance of remission in patients suffering of Chron’s disease.  59 
Lactobacillus species are the most investigated probiotics in IBDs. L. acidophilus, L. fermentum, L. gasseri 60 
and L. rhamnosus were found to modulate adherence junctions proteins (AJP) E-cadherin and -61 
catenin expression and complex formation in T84 epithelial cells. In addition, these Lactobacillus 62 
species increased AJP phosphorylation and levels of protein kinase C (PKC) 8. In TNF-α-stimulated 63 
Caco-2 cells, L. rhamnosus CNCM I-3690, L. rhamnosus LGG, better than other 22 Lactobacillus strains, 64 
demonstrated to protect barrier integrity measured by Trans-Epithelial Electrical Resistance (TEER). 65 
L. rhamnosus CNCM I-3690 mechanism of action was found to involve NF-B block. The same strain, 66 
as the commensal Faecali bacterium prausnitzii A2-165, was found to be also effective in protecting 67 
barrier hyper-permeability in mice 11. L. acidophilus was also investigated and in a large in vivo and 68 
in vitro study 12, revealing that surface layer protein of bacterium SlpA exerts a regulatory role in 69 
mitigating colitis by interacting with intestinal pattern recognition receptors, in particular SIGNR3 70 
specific intracellular adhesion molecule-3 grabbing non-integrin homolog-related 3. 71 
In this experimental research, for the first time we investigated a fixed combination of probiotics L. 72 
reuteri DSM 25175 and L. acidophilus DSM 24936 and a Chamomilla recutita L. oleolite in an extravirigin 73 
olive oil solution “Colikind Gocce®” (Schwabe Pharma Italia), a food supplement registered and 74 
authorized in Italy, formulated with particular reference for children to maintain intestinal health. 75 
We evaluate the effect of the product in Caco-2 cell monolayer exposed to INF-γ+TNF-α, or to LPS, 76 
chosen as experimental models of endogenous inflammatory stimuli [13]. Functional and 77 
morphological biomarkers of intestinal barrier integrity were investigated. 78 
2. Materials and Methods  79 
2.1 Intestinal cell monolayer preparation and treatment 80 
Caco-2 cells, obtained from American Type Culture Collection, were grown in high glucose 81 
Dulbecco's modified Eagle's media (DMEM) supplemented with 10% FBS, 1% L-glutamine and 1% 82 
penicillin/streptomycin and maintained under a humidified atmosphere of 5% CO2 in air, at 37°C. 83 
Experimental inflammatory condition in Caco-2 cell monolayers was induced by the exposure for 84 
different times, according to the assays, to 10 ng/ml recombinant human INF-γ for 3 hours and then 85 
10 ng/ml TNF-α or to LPS 250 µg/ml. The fixed combination of probiotics and C. recutita oleolite in 86 
extra virgin oil was used (Colikind Gocce, containing 2*109 CFU per ml of both typized Lactobacillus 87 
strains and 10 mg/ml of C. recutita oleolite with drug:extract 1:2, in extra virgin oil) Twenty-four hours 88 
pre-treatment with the fixed combination of probiotics and herbal extracts diluted 400 folds, 89 
corresponding to 5*106 CFU, was applied before inflammatory stimuli. Reagents for cell cultures were 90 
from Lonza whereas INF-γ, TNF-α and LPS were from Sigma-Aldrich.  91 
  92 
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2.2 Trans-epithelial electrical resistance (TEER) assay 93 
Cells were seeded on Transwell™ polyester membrane cell culture inserts (1.0 cm2 growth surface 94 
area, 0.45 µm pore size; BD Falcon™) in 24-well plates and incubated with DMEM at 37 °C in a 95 
humidified atmosphere and 5% CO2. Culture media were replaced every two days until confluent 96 
monolayer was obtained within 20-21 days. A pretreatment of 24 hours was done adding the fixed 97 
combination of probiotics and herbal extracts to the apical chamber. The TEER assay was performed 98 
in HBSS (Hanks' Balanced Salt solution, Lonza) after an equilibration period at room temperature. 99 
Treatments were added to the apical chamber and inflammatory stimuli to the basal chamber. 100 
Millicell® ERS meter, Millipore Corporation connected to a pair of chopstick electrodes were inserted 101 
in the donor and receiver chambers and the 24 hours of TEER variation was recorded. TEER was 102 
expressed as percentage of resistance, normalized to initial value. 103 
 104 
2.3 Paracellular permeability assay 105 
Fluorescein isothiocyanate flux across Caco-2 cell monolayers was used as measure of paracellular 106 
permeability. After recording of the 24 hours TEER variation, the apical medium was replaced with 107 
a solution of fluorescein isothiocyanate in HBSS (Hanks’ Balanced Salt solution, Lonza). After 30 108 
minutes of incubation at 37 °C, 200 µl were taken from the basal chamber and the amount of 109 
fluorescein permeated was measures using a Multilabel Plate Reader VICTOR X3 (PerkinElmer) at 110 
excitation 480 nm—emission 530 nm. 111 
 112 
2.4 Immunofluorescence microscopy 113 
Cells were seeded on glass coverslips in 24-well plates and cultured until confluence was obtained. 114 
24 hours treatments with the fixed combination of probiotics and herbal extracts and inflammatory 115 
stimuli were done according to the experimental protocol as described. Cells monolayers were fixed 116 
with 4% p-formaldehyde for 15 min, permeabilized with triton 0.1% for 5 min and double-labelled 117 
by incubating with primary antibodies for occludin and ZO-1 proteins for 1 hour at 37 °C. After PBS 118 
wash, they were incubated with secondary antibodies Alexa Fluor 488 anti-mouse for occludin and 119 
Alexa Fluor 536 anti-rabbit for ZO-1 for 1 hour at 37 °C. The coverslips were mounted on glass slides 120 
by using Mowiol 40–88 (Sigma, St Louis, MO). Images were acquired through confocal microscope 121 
(Zeiss LSM 800, 60X magnification). 122 
 123 
2.5 Statistical Analysis 124 
The statistical analysis was performed using GraphPad Prism version 3 for Windows (GraphPad 125 
Software, San Diego, CA, USA). Results are presented as mean ± SEM. The unpaired t-test was used 126 
to compare TEER values and paracellular permeability and P values <0.05 were considered 127 
statistically significant.  128 
3. Results 129 
TEER and paracellular permeability are considered specific and sensitive biomarkers of the intestinal 130 
barrier integrity and function [1]. Thus, the effect of the fixed combination of probiotics and herbal 131 
extracts 5*106 CFU was measured on TEER and permeability in Caco-2 cell monolayer in basal 132 
condition and after exposure to INF-γ+TNF-α or LPS (Fig. 1-2). 133 
Twenty-four hours of the fixed combination of probiotics and herbal extracts treatment did not cause 134 
any alteration of basal TEER (Fig. 1A). LPS treatment determined a time-dependent reduction of more 135 
than 50% of TEER T0 value; this effect is significantly prevented by pretreatment with the fixed 136 
combination of probiotics and herbal extract, which maintain the TEER values higher in respect to 137 
inflammatory stimulus in particular in prolonged stimulation, indicating a lower permeability in 138 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 29 December 2017                   doi:10.20944/preprints201712.0199.v1
 4 of 9 
 
presence of the pre-treatment. At 21 and 24 hours the pre-treatment did increase TEER respectively 139 
from 34.89% of the inflammatory stimulus alone to 46.32% and from 33.90% to 41.68% (Fig. 1B). 140 
Also treatment with INF-γ + TNF-α significantly decreased TEER value (Fig. 1C) and the fixed 141 
combination of probiotics and herbal extracts showed a tendency to prevent the epithelial damage 142 
induced by the inflammatory stimulus which was found statistically significant at 24 hours (from 143 
40.87% of the inflammatory stimulus alone to 50.33%, p<0.05).  144 
 145 
 146 
Figure 1. Effect of the fixed combination of probiotics and herbal extracts on transepithelial electrical resistance 147 
in Caco2 cells monolayer. 148 
A) The fixed combination of probiotics and herbal extracts 5*106 CFU; B) The fixed combination of probiotics and 149 
herbal extracts 5*106 CFU with LPS 250 µg/ml, C) The fixed combination of probiotics and herbal extracts 5*106 150 
CFU with INF-γ+TNF-α 10 ng/ml;. Data are expressed as mean ± SEM percentage of baseline TEER value of n = 151 
3/4 experiments. 152 
***p<0.001 treatment vs Control;#p<0.05, ##p<0.01, #p<0.05 pre-treatment vs inflammatory stimulus.  153 
 154 
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Sodium fluorescein is a validated biomarker of leakage used in the paracellular permeability assay 155 
[1]. The assay was applied to evaluate the effect of inflammatory stimuli in presence or absence of the 156 
treatment in Caco-2 cell monolayer. The fixed combination of probiotics and herbal extracts did not 157 
influence the cell permeability in basal condition. Pre-treatment was found to counteract the LPS 158 
induced paracellular permeability increase by 41.25%, but data obtained in replicates were not 159 
statistically significant (Fig. 2A). Also the treatment with INF-γ+TNF-α induced an increase in 160 
cellular permeability that in this case was significantly counteracted by the pre-treatment with the 161 
fixed combination of probiotics and herbal extracts (- 82.67% compared to stimulus, Fig. 2B).  162 
 163 
Figure 2. Effect of the fixed combination of probiotics and herbal extracts on Caco-2 cell monolayers paracellular 164 
permeability, measured by isothiocyanate fluorescein assay. A) The fixed combination of probiotics and herbal 165 
extracts 5*106 CFU + LPS; B) The fixed combination of probiotics and herbal extracts 5*106 CFU + INF-γ+TNF-α. 166 
Data are shown as mean ± SEM percentage of basal fluorescent intensity (n = 3/4 experiments).  167 
*p<0.05, **p<0,01 treatment vs control, #p<0.05 treatment vs stimulus 168 
 169 
ZO-1 and occludin belong to TJ proteins forming a continuous, circumferential, belt-like structure at 170 
the boundary between the apical and basolateral membrane domains in epithelial and endothelial 171 
cells. By constituting a regulated diffusion barrier, TJs establish separate compartments, that are 172 
crucial for the exchange of substances through the paracellular pathway, and are considered useful 173 
biomarkers of the epithelial barrier function/dysfunction [14].  174 
Therefore the effect of the fixed combination of probiotics and herbal extracts on ZO-1 and occludin 175 
was studied as possible mechanism involved in protection from inflammatory damage. Results in 176 
Fig 3 show that in untreated Caco-2 cell monolayer ZO-1 and occludin immunofluorescence signals 177 
localize at the apical membrane junctions, appearing as continuous belt-like structures encircling the 178 
cell. This asset was not modified by the treatment (Fig. 3A-B).  179 
 180 
 181 
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 182 
 183 
 184 
Figure 3. The fixed combination of probiotics and herbal extracts effect on occludin and zonula occludens (ZO-185 
1) TJ proteins in Caco-2 cell monolayers. A) Control; B) Monolayer treated with the fixed combination of 186 
probiotics and herbal extracts 5*106 CFU; C) Cells treated with INF-γ+TNF-α 10 ng/ml; D) Monolayer treated 187 
with the fixed combination of probiotics and herbal extracts 5*106 CFU and INF-γ+TNF-α 10 ng/ml; E) Monolayer 188 
treated with LPS 250 µg/ml; F) Monolayer treated with LPS 250 µg/ml and the fixed combination of probiotics 189 
and herbal extracts 5*106 CFU. Images were collected by confocal laser-scanning microscope. 190 
 191 
By contrast, INF-γ+TNF-α and LPS (Fig. 3C-E) cause alteration of TJs. Particularly, in INF-γ+TNF-α 192 
and LPS treated cells, it appears that occludin is striking internalized and that the staining of 193 
membrane ring structure is irregular. These alterations in TJ proteins caused by the inflammatory 194 
stimuli was prevented by the fixed combination of probiotics and herbal extracts as shown in figure 195 
3D-F. 196 
 197 
4. Discussion 198 
In Caco-2 cell monolayers the fixed combination of Lactobacillus strains and C. recutita oleolite extract 199 
in olive oil was found to be able to preserve the integrity and functioning of intestinal barrier from 200 
damage caused by inflammatory stimuli LPS or INF-γ + TNF-α. Inflammation is crucial in the 201 
destruction of intestinal barrier in infections caused by viruses and bacteria. Caco-2 cells exposed to 202 
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INF-γ + TNF-α or LPS have been chosen as a convenient experimental paradigm of intestinal 203 
inflammation, for specific reasons. The human intestinal Caco-2 cell line has been widely used as an 204 
experimental model of intestinal barrier. The parental cell line, originally obtained from an 205 
adenocarcinoma of the human colon, spontaneously differentiates, leading to the expression of 206 
various morphological and functional characteristics of the mature enterocyte. The immortalized 207 
Caco-2 cells are a model to study pharmacological modulation of epithelial barrier and integrity of 208 
TJ [15–17]. It is known that intact intestinal barrier prevents the incoming of pathogens and antigenic 209 
molecules into mucosa and avoid their contact with immune system; however, in some tissues, such 210 
as colon, the antioxidant capacity is low and can facilitate inflammatory lesions. The pro-211 
inflammatory cytokines contribute to the onset and/or propagation of damage within the intestinal 212 
barrier and can be used to reproduce a comparable endogenous inflammation in cell cultures [18, 213 
19,20, 21]. In fact, when we exposed Caco-2 cell monolayer to INF- + TNF-α or LPS, TEER decreased 214 
significantly and the paracellular permeability increased. Interestingly, these alterations were 215 
prevented by pre-treatment with the fixed combination of lactobacilli and C. recutita in olive oil. Our 216 
work confirmed previous papers reporting intestinal permeability preservation by lactobacilli [11] 217 
and we can address L. reuteri and L. acidophilus an important role in observed biological effect. 218 
Furthermore, olive oil, used in this case at 0.25% V/V ca. undoubtedly contributed to the anti-219 
inflammatory effect in Caco-2 cells, considering the putative action of oil polyphenols on Caco-2, as 220 
recently reported also by Incani et al. [22]. C. recutita extract, used in this case at 25 g/ml could 221 
improve the anti-inflammatory effectiveness of the product as well, as suggested by literature on this 222 
herbal medicine and recently confirmed by Ortiz et al. [23]. Further investigations on the role of single 223 
components could be interesting, but this first study highlighted the effectiveness of the whole 224 
composition as a synergy among all active ingredients. 225 
In human gut a single layer of epithelial cells separates intestinal lumen from underlying lamina 226 
propria, and the space between these cells is sealed by TJ proteins, such as occludin, ZO-1 and claudins 227 
[24-26] TJs are essential to maintain physiologic processes in all organs containing epithelia and are 228 
critical structure in the intestinal barrier, where they modulate cell polarity, proliferation, and 229 
differentiation [27]. The delocalization of occludin and ZO-1 from the membrane is associated with 230 
intestinal barrier dysfunction and increased permeability [25, 13]. Various stimuli, including 231 
pathogens, oxidative stress, and pro-inflammatory cytokines can affect these proteins [24, 20]; it has 232 
been observed that treatment with TNF-α and INF-γ induces a redistribution process that causes, in 233 
both cell culture and animal models, barrier alterations comparable to those observed in IBD [28, 21, 234 
29]. According to literature, our results demonstrated that INF-γ+TNF-α, as well LPS, caused 235 
occludin and ZO-1 localization on Caco-2 cell membrane and the fixed combination of probiotics and 236 
herbal extracts efficaciously prevented TJs translocation.  237 
TJ barrier disruption and increased paracellular permeability, followed by permeation of luminal 238 
pro-inflammatory molecules, can induce activation of mucosal immune system, resulting in 239 
sustained inflammation and tissue damage. 240 
Recent studies showed that knockdown of occludin induces an increase in paracellular permeability 241 
to macromolecules, which indicates that occludin plays a role in the maintenance and assembly of 242 
TJs [30]. 243 
 244 
5. Conclusions 245 
Targeting the re-establishment of intestinal barrier function is still a challenge in acute or chronic 246 
enteropathies and our findings revealed that a fixed combination of lactobacilli and C. recutita extract 247 
in extra virgin olive oil exerted a protective role against barrier dysfunction by increasing TEER, 248 
decreasing permeability, increasing occludin and ZO-1 proteins expression in LPS and INF-/TNF- 249 
induced inflammation.  250 
 251 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 29 December 2017                   doi:10.20944/preprints201712.0199.v1
 8 of 9 
 
Author Contributions: MM and IC conceived and designed the experiments; VC and DC performed the 252 
experiments; VB, MCG, ER, MB, PG and ER analyzed the data; VC, PG, MB and MM wrote the paper.  253 
Conflicts of Interest: IC is the head of scientific affairs of Schwabe Pharma Italia. 254 
References 255 
 256 
1. Catanzaro, D.; Rancan, S.; Orso, G.; Dall’Acqua, S.; Brun, P.; Giron, M.C.; Carrara, M.; Castagliulo, I.; 257 
Ragazzi, E.; Caparrotta, L.; Montopoli, M. Boswellia serrata Preserves Intestinal Epithelial Barrier from 258 
Oxidative and Inflammatory Damage. PLoS One. 2015,10(5), e0125375. DOI: 10.1371/journal. pone.0125375.  259 
2. Xavie, R.J.; Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007, 448, 260 
427–434. DOI: 10.1038/nature06005. 261 
3. Ping, L; Ying, Z; Xin, C. Drugs for Autoimmune Inflammatory Diseases: from small molecule compounds 262 
to anti-TNF Biologics. Front Pharmacol 2017, 8, 460. DOI: 10.3389/fphar.2017.00460. 263 
4. Guidi, L., Pugliese, D., & Armuzzi, A. (2011). Update on the management of inflammatory bowel disease: 264 
specific role of adalimumab. Clinical and experimental gastroenterology, 4, 163. DOI: 10.2147/CEG.S14558 265 
5. Larussa, T; Imeneo, M; Luzza, F. Potential role of nutraceutical compounds in inflammatory bowel disease. 266 
World J Gastroenterol 2017, 23(14), 2483-2492. DOI: 10.3748/wjg.v23.i14.2483 267 
6. Guo, B.J.; Bian, Z.X.; Qiu, H.C.; Wang, Y.T.; Wang, Y. Biological and clinical implications of herbal medicine 268 
and nature products for the treatment of inflammatory bowel disease. Ann NY AcadSci 2017, 1401, 37-48. 269 
DOI: 10.1111/nyas.13414. 270 
7. Farzaei, M.H.; Bahramsoltani, R.; Abdolghaffari A.H.; Sodagari, H.R.; Esfahani, S.A.; Rezaei, N. A 271 
mechanistic review on plant-derived natural compounds as dietary supplements for prevention of 272 
inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2016, 10(6), 745-58. DOI: 273 
10.1586/17474124.2016.1145546.  274 
8. Hummel, S.; Veltman, K.; Christoph, C.; Sonnenborn, U.; Schmidt, M.A. Differential Targeting of the E-275 
Cadherin/-Catenin complex by Gram-Positive Probiotic Lactobacilli improves Epithelial Barrier Function. 276 
Appl Environ Microbiol. 2012, 78, 1140-1147. DOI: 10.1128/AEM.06983-11. 277 
9. Korada, S.K.; Yarla, N.S.; Bishayee, A; Aliev, G; Lakshimi, A.K.; Arunase, M.K.; Dhananjaya, B.L.; Mishra, 278 
V. Can Probiotics Cure Inflammatory Bowel Diseases? Curr Pharm Des 2016, 22(7), 904-917. DOI: 279 
10.2174/1381612822666151209153249. 280 
10. Ghouri, A; Richards, D.M.; Rahimi, E.F.; Krill, T.J.; Jelinek, K.A.; DuPont, A.W. Systematic review of 281 
randomized controlled trials of probiotics, prebiotics, and symbiotic in inflammatory bowel disease. 282 
ClinExpGastroenterol. 2014, 7, 473-487. DOI:10.2147/CEG.S27530. 283 
11. Laval, L.; Martin, R.; Natividad, J.N; Chain, F.; Miquel, S.; C Desclée de Maredsous, C.; Capronnier, S.; 284 
Sokol, H; Verdu, E.F.; Van HylckamaVlieg, J.E.; Bermùdez-Humaràn, L.G.; Smokvina, T.; Langella, P. 285 
Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecali bacterium prausnitzii A2-165 286 
exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes. 2015, 6(1), 1-287 
9. DOI:10.4161/19490976.2014.990784. 288 
12. Lightfoot, Y.L.; Selle, K.; Yang, T.; Goh, Y.J.; Sahay, B.; Zadeh, M.; Owen, J.L.; Colliou, N.; Eric, L.; 289 
Johannssen, T; Lepenies, B.; Klaenhammer, T.R.; Mohamadzadeh, M. SIGNR3-dependent immune 290 
regulation by Lactobacillus acidophilus surface layer protein A in colitis.EMBO J.2015, 34(7): 881–895, DOI: 291 
10.15252/embj.201490296. 292 
13. Wang, F.; Graham, W.V.; Wang, Y; Witkowski, E.D.; Scwarz, B.T.; Turner, J.R. Interferon- and Tumor 293 
Necrosis Factor-Synergize to Induce Intestinal Epithelial Barrier Dysfunction by Up-Regulating Myosin 294 
Light Chain Kinase Expression. American Journal of Pathology.2005, 166(2): 409-419. 295 
DOI:http://dx.doi.org/10.1016/S0002-9440(10)62264-X 296 
14. Suzuki, T. Regulation of intestinal epithelial permeability by tight junctions. Cellular and molecular life 297 
sciences. 2013, 70(4), 631-659. DOI: 10.1007/s00018-012-1070-x. 298 
15. Peterson, M. D.; Mooseker, M. S. An in vitro model for the analysis of intestinal brush border assembly. I. 299 
Ultrastructural analysis of cell contact-induced brush border assembly in Caco-2BBe cells. Journal of Cell 300 
Science. 1993, 105(2), 445-460. 301 
16. Fleet, J. C.; Wang, L.; Vitek, O.;Craig, B. A.; Edenberg, H. J. Gene expression profiling of Caco-2 BBe cells 302 
suggests a role for specific signaling pathways during intestinal differentiation. Physiological genomics. 2003, 303 
13(1), 57-68. DOI: 10.1152/physiolgenomics.00152.2002 304 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 29 December 2017                   doi:10.20944/preprints201712.0199.v1
 9 of 9 
 
17. Mariadason, J. M., Arango, D., Corner, G. A., Arañes, M. J., Hotchkiss, K. A., Yang, W., & Augenlicht, L. H. 305 
(2002). A gene expression profile that defines colon cell maturation in vitro.Cancer Research. 2002, 62(16), 306 
4791-4804. 307 
18. Zhu, H., & Li, Y. R. (2012). Oxidative stress and redox signaling mechanisms of inflammatory bowel 308 
disease: updated experimental and clinical evidence. Experimental Biology and Medicine. 2012, 237(5), 474-309 
480. DOI: 10.1258/ebm.2011.011358. 310 
19. Pavlick, K. P.; Laroux, F. S.; Fuseler, J.; Wolf, R. E.; Gray, L.; Hoffman, J.; Grisham, M. B. Role of reactive 311 
metabolites of oxygen and nitrogen in inflammatory bowel disease 1, 2. Free Radical Biology and Medicine. 312 
2002, 33(3), 311-322. DOI: https://doi.org/10.1016/S0891-5849(02)00853-5. 313 
20. Wang, F., Schwarz, B. T., Graham, W. V., Wang, Y., Su, L., Clayburgh, D. R., ... & Turner, J. R. (2006). IFN-314 
γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier 315 
dysfunction. Gastroenterology.2006, 131(4), 1153-1163. DOI: 10.1053/j.gastro.2006.08.022. 316 
21. Hering, N. A.; Fromm, M.; Schulzke, J.D. Determinants of colonic barrier function in inflammatory bowel 317 
disease and potential therapeutics. The Journal of physiology. 2012, 590(5), 1035-1044. DOI: 318 
10.1113/jphysiol.2011.224568. 319 
22. Incani, A.; Serra, G.; Atzeri, A.; Melis, M.P.; Serreli, G.; Bandino, G.; Sedda, P.; Campus, M.; Tuberoso, C.I.; 320 
Deiana, M. Extra virgin olive oil phenolic extracts counteract the pro-oxidant effect of dietary oxidized 321 
lipids in human intestinal cells. Food Chem Toxicol. 2016, 90: 171-80. DOI: 10.1016/j.fct.2016.02.015. 322 
23. Ortiz, M.I.; Cariño-Cortés, R.; Ponce-Monter, H.A.; González-García, M.P.; Castañeda-Hernández, G.; 323 
Salinas-Caballero M. Synergistic Interaction of Matricaria Chamomilla Extract with Diclofenac and 324 
Indomethacin on Carrageenan-Induced Paw Inflammation in Rats. Drug Dev Res. 2017, 78(7): 360-367. DOI: 325 
10.1002/ddr.21401. 326 
24. Turner, J.R. Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology. 2009, 327 
9(11), 799-809. 328 
25. Shin, K.; Fogg, V. C.; Margolis, B. Tight junctions and cell polarity. Annu. Rev. Cell Dev. Biol. 2006, 22, 207-329 
235.DOI: 10.1146/annurev.cellbio.22.010305.104219. 330 
26. Harhaj, N. S.; Antonetti, D. A. Regulation of tight junctions and loss of barrier function in pathophysiology. 331 
The international journal of biochemistry & cell biology. 2004, 36(7), 1206-1237. DOI: 10.1016/j.biocel.2003.08.007. 332 
27. Liu, H.; Wang, P.; Cao, M.; Li, M.; Wang, F. Protective role of oligomycin against intestinal epithelial barrier 333 
dysfunction caused by IFN-γ and TNF-α. Cellular Physiology and Biochemistry.2013,29(5-6), 799-808. DOI: 334 
https://doi.org/10.1159/000188076. 335 
28. Li, Q.; Zhang, Q.;Wang, M.; Zhao, S.; Ma, J.; Luo, N.; Li, J. Interferon-γ and tumor necrosis factor-α disrupt 336 
epithelial barrier function by altering lipid composition in membrane micro domains of tight junction. 337 
Clinical Immunology. 2008, 126(1), 67-80. DOI: https://doi.org/10.1016/j.clim.2007.08.017. 338 
29. John, L. J.; Fromm, M.; Schulzke, J. D. Epithelial barriers in intestinal inflammation. Antioxidants& redox 339 
signaling. 2011, 15(5), 1255-1270. DOI: https://doi.org/10.1089/ars.2011.3892. 340 
30. Lee, S. H. (2015). Intestinal permeability regulation by tight junction: implication on inflammatory bowel 341 
diseases. Intestinal research. 2015, 13(1), 11-18. 342 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 29 December 2017                   doi:10.20944/preprints201712.0199.v1
